Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1

Molecular Neurodegeneration
David A QuallsDavid R Borchelt

Abstract

Mutations in the gene encoding superoxide dismutase 1 (SOD1) account for about 20% of the cases of familial amyotrophic lateral sclerosis (fALS). It is well established that mutations in SOD1, associated with fALS, heighten the propensity of the protein to misfold and aggregate. Although aggregation appears to be a factor in the toxicity of mutant SOD1s, the precise nature of this toxicity has not been elucidated. A number of other studies have now firmly established that raising the levels of wild-type (WT) human SOD1 (hSOD1) proteins can in some manner augment the toxicity of mutant hSOD1 proteins. However, a recent study demonstrated that raising the levels of WT-hSOD1 did not affect disease in mice that harbor a mouse Sod1 gene (mSod1) encoding a well characterized fALS mutation (G86R). In the present study, we sought a potential explanation for the differing effects with WT-hSOD1 on the toxicity of mutant hSOD1 versus mutant mSod1. In the cell culture models used here, we observe poor interactions between WT-hSOD1 and misfolded G86R-mSod1, possibly explaining why over-expression of WT-hSOD1 does not synergize with mutant mSod1 to accelerate the course of the disease in mice.

References

Jan 1, 1975·Annual Review of Biochemistry·I Fridovich
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H E PargeJ A Tainer
Sep 11, 1990·Nucleic Acids Research·S Mizushima, S Nagata
Oct 1, 1974·The Journal of Clinical Investigation·M L Salin, J M McCord
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
Jan 1, 1994·European Biophysics Journal : EBJ·I BertiniG T Mullenbach
Dec 21, 2002·The British Journal of Nutrition·George FrancisKlaus Becker
Jun 26, 2004·Annual Review of Neuroscience·Lucie I BruijnDon W Cleveland
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Han-Xiang DengTeepu Siddique
Nov 17, 2006·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Sagar D KhareNikolay V Dokholyan
May 9, 2007·Nature Medicine·Rishi RakhitAvijit Chakrabartty
Feb 29, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Dick JaarsmaCasper C Hoogenraad
Dec 17, 2008·Journal of Neurochemistry·Mercedes PrudencioDavid R Borchelt
Feb 24, 2009·Human Molecular Genetics·Lijun WangRaymond P Roos
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Celeste M KarchDavid R Borchelt
Jun 2, 2009·Human Molecular Genetics·Mercedes PrudencioPeter M Andersen
Jun 25, 2010·Neurobiology of Disease·Jean-Nicolas AudetJean-Pierre Julien
Sep 28, 2010·Human Molecular Genetics·Mercedes PrudencioDavid R Borchelt
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jared R AuclairJeffrey N Agar
Nov 19, 2011·Molecular Neurodegeneration·Mercedes Prudencio, David R Borchelt

❮ Previous
Next ❯

Citations

Jul 2, 2014·Frontiers in Aging Neuroscience·Megan W BourassaLisa M Miller
Jan 13, 2015·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·S P Keerthana, P Kolandaivel

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
transfections
fluorescence microscopy

Software Mentioned

GraphPad PRISM

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
Loretta FerreraCecilia Garrè
© 2021 Meta ULC. All rights reserved